Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Allergan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Allergan's 2013 CNS (central nervous system) sales performance.

Where next in Alzheimer’s disease R&D?

Where next in Alzheimer’s disease R&D?

Sosei Heptares landed a $125m upfront payment from Allergan on the strength of its work to create more selective M1 agonists, although parts of its clinical programmes are on hold pending

Depression drug failure adds to Allergan's woes

Depression drug failure adds to Allergan's woes Axe hangs over remaining monotherapy and suicidality trials. Allergan’s novel treatment for major depressive disorder (MDD) rapastinel has failed in three pivotal phase 3 studies. ... Allergan says an interim analysis of rapastinel as a relapse

2019: CRISPR and therapeutic gene editing comes of age

2019: CRISPR and therapeutic gene editing comes of age In November, the US Food and Drug Administration (FDA) approved Editas Medicine’s Investigational New Drug (IND) application for a phase 1/2 trial of its Allergan-partnered CRISPR drug

Cutting through the noise: CRISPR

Cutting through the noise: CRISPR Editas Medicine and partner Allergan plan to initiate a phase 1/2 clinical trial this year, with patient dosing set to begin in the second half of 2019.

New faces at imc, GCI Health and Lighthouse US

New faces at imc, GCI Health and Lighthouse US Massey has more than 20 years’ pharmaceutical industry leadership experience and has served in various positions for Allergan, Shire and Merck Sharp &Dohme.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics